Domov › Bipolarna motnja › Georgia
Klinične študije za Bipolarna motnja v Georgia
9 študij za Bipolarna motnja išče udeležence na lokacijah v Georgia.
Mesta v Georgia
Uradno besedilo študije (angleško)
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- CenExeli Research LLC, Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExeli Research LLC 1, Savannah
Vključevanje udeležencevFaza 3
Starost 5–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- CenExeli Research LLC, Atlanta
- CenExeli Research LLC 1, Savannah
Vključevanje udeležencevFaza 3
Starost 10–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06372964A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Atlanta Center for Medical Research, Atlanta
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07286175A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Synexus Clinical Research, Inc., Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExel iResearch, Decatur
- in še 1
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Georgia Psychiatric Consultants and Advanced Discovery Research /ID# 279438, Atlanta
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT06696755Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Decatur
Vključevanje udeležencevFaza 1
Starost 10–17 · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05025605A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- CenExel iResearch, LLC, Savannah
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07140913Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
Vključevanje udeležencevOpazovalna študija
Starost 18–40 · Vsi spoli · Posodobljeno 10. mar. 2026 · NCT06740383Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.